Evidence map›Paper›PMID 30887811›Full record

ArticleJournal of proteome research2019

An Unbiased Lipid Phenotyping Approach To Study the Genetic Determinants of Lipids and Their Association with Coronary Heart Disease Risk Factors.

Eric L Harshfield, Albert Koulman, Daniel Ziemek, Luke Marney, Eric B Fauman, Dirk S Paul, David Stacey, Asif Rasheed, Jung-Jin Lee, Nabi Shah and 20 more

Abstract read
In one paragraph

Article in Journal of proteome research, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 37 papers.

0numbers the graph read from it
0cells of the map it votes in
37citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

37 citing papers in PubMed.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

30 authors.

Eric L HarshfieldMRC/BHF Cardiovascular Epidemiology Unit, Department of Public Health and Primary Care , University of Cambridge , Cambridge CB1 8RN , U.K.ORCID 0000-0001-8767-0928
Albert KoulmanCore Metabolomics and Lipidomics Laboratory , National Institute for Health Research Cambridge Biomedical Research Centre , Cambridge CB2 0QQ , U.K.
Daniel ZiemekInflammation and Immunology, Pfizer Worldwide Research & Development , 10785 Berlin , Germany.
Luke MarneyCollege of Science and Engineering , Seattle University , Seattle , Washington 98122 , United States.
Eric B FaumanGenomic Sciences and Technologies, Pfizer Worldwide Research & Development , Cambridge , Massachusetts 02139 , United States.
Dirk S PaulMRC/BHF Cardiovascular Epidemiology Unit, Department of Public Health and Primary Care , University of Cambridge , Cambridge CB1 8RN , U.K.
David StaceyMRC/BHF Cardiovascular Epidemiology Unit, Department of Public Health and Primary Care , University of Cambridge , Cambridge CB1 8RN , U.K.
Asif RasheedCenter for Non-Communicable Diseases , Karachi 75300 , Pakistan.
Jung-Jin LeeDepartment of Medicine , Mayo Hospital , Lahore 54000 , Pakistan.
Nabi ShahCenter for Non-Communicable Diseases , Karachi 75300 , Pakistan.
Sehrish JabeenCenter for Non-Communicable Diseases , Karachi 75300 , Pakistan.
Atif ImranCenter for Non-Communicable Diseases , Karachi 75300 , Pakistan.
Shahid AbbasDepartment of Cardiology , Faisalabad Institute of Cardiology , Faisalabad 38000 , Pakistan.
Zoubia HinaDepartment of Cardiology , Faisalabad Institute of Cardiology , Faisalabad 38000 , Pakistan.
Nadeem QamarNational Institute of Cardiovascular Disorders , Karachi 75510 , Pakistan.
Nadeem Hayyat MallickPunjab Institute of Cardiology , Lahore 42000 , Pakistan.
Zia YaqoobKarachi Institute of Heart Diseases , Karachi 75950 , Pakistan.
Tahir SaghirNational Institute of Cardiovascular Disorders , Karachi 75510 , Pakistan.
Syed Nadeem Hasan RizviNational Institute of Cardiovascular Disorders , Karachi 75510 , Pakistan.
Anis MemonNational Institute of Cardiovascular Disorders , Karachi 75510 , Pakistan.
Syed Zahed RasheedKarachi Institute of Heart Diseases , Karachi 75950 , Pakistan.
Fazal-Ur-Rehman MemonRed Crescent Institute of Cardiology , Hyderabad 71500 , Pakistan.
Irshad Hussain QureshiDepartment of Medicine , Mayo Hospital , Lahore 54000 , Pakistan.
Muhammad IshaqKarachi Institute of Heart Diseases , Karachi 75950 , Pakistan.
Philippe FrossardCenter for Non-Communicable Diseases , Karachi 75300 , Pakistan.
John DaneshMRC/BHF Cardiovascular Epidemiology Unit, Department of Public Health and Primary Care , University of Cambridge , Cambridge CB1 8RN , U.K.
Danish SaleheenCenter for Non-Communicable Diseases , Karachi 75300 , Pakistan.
Adam S ButterworthMRC/BHF Cardiovascular Epidemiology Unit, Department of Public Health and Primary Care , University of Cambridge , Cambridge CB1 8RN , U.K.
Angela M WoodMRC/BHF Cardiovascular Epidemiology Unit, Department of Public Health and Primary Care , University of Cambridge , Cambridge CB1 8RN , U.K.
Julian L GriffinDepartment of Biochemistry and Cambridge Systems Biology Centre , University of Cambridge , Cambridge CB2 1GA , U.K.ORCID 0000-0003-1336-7744

Funding

British Heart Foundation RG/13/13/30194British Heart Foundation RG/18/13/33946European Research Council SP/09/002Medical Research Council G0800270Medical Research Council MC_EX_G0800783Medical Research Council MC_PC_13030Medical Research Council MC_UP_A090_1006Medical Research Council MC_UU_00014/5Medical Research Council MC_UU_12012/5Medical Research Council MR/P011705/1Medical Research Council MR/P01836X/1Wellcome TrustWellcome Trust 105602/Z/14/Z
6 · The paper itself

Abstract

Direct infusion high-resolution mass spectrometry (DIHRMS) is a novel, high-throughput approach to rapidly and accurately profile hundreds of lipids in human serum without prior chromatography, facilitating in-depth lipid phenotyping for large epidemiological studies to reveal the detailed associations of individual lipids with coronary heart disease (CHD) risk factors. Intact lipid profiling by DIHRMS was performed on 5662 serum samples from healthy participants in the Pakistan Risk of Myocardial Infarction Study (PROMIS). We developed a novel semi-targeted peak-picking algorithm to detect mass-to-charge ratios in positive and negative ionization modes. We analyzed lipid partial correlations, assessed the association of lipid principal components with established CHD risk factors and genetic variants, and examined differences between lipids for a common genetic polymorphism. The DIHRMS method provided information on 360 lipids (including fatty acyls, glycerolipids, glycerophospholipids, sphingolipids, and sterol lipids), with a median coefficient of variation of 11.6% (range: 5.4-51.9). The lipids were highly correlated and exhibited a range of associations with clinical chemistry biomarkers and lifestyle factors. This platform can provide many novel insights into the effects of physiology and lifestyle on lipid metabolism, genetic determinants of lipids, and the relationship between individual lipids and CHD risk factors.

Indexed as

BiomarkersCoronary DiseaseFemaleGenetic VariationGlycerophospholipidsHumansLipid MetabolismLipidsMaleMiddle AgedRisk FactorsSphingolipidsSterolsBiomarkersGlycerophospholipidsLipidsSphingolipidsSterolscoronary heart diseasegeneticslipidomicsmass spectrometryprotocol

Identifiers

PMID30887811
PMCPMC6558644

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.